Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2018-01-12
DOI
10.1093/ndt/gfy012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Randomized Trial of Vitamin D Supplementation on Vascular Function in CKD
- (2017) Vivek Kumar et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2–5 and on dialysis
- (2017) Rukshana Shroff et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD)
- (2017) Kidney International Supplements
- Genetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD
- (2016) A. Doyon et al. Clinical Journal of the American Society of Nephrology
- The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
- (2016) Alexander Grabner et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children
- (2016) Svenja Kristin Kunert et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Pragmatic Clinical Trials in CKD: Opportunities and Challenges
- (2016) I. H. de Boer et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Complement in Kidney Disease: Core Curriculum 2015
- (2015) Joshua M. Thurman AMERICAN JOURNAL OF KIDNEY DISEASES
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- FGF23 Regulates Bone Mineralization in a 1,25(OH)2D3and Klotho-Independent Manner
- (2015) Sathish Kumar Murali et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Normal 25-Hydroxyvitamin D Levels Are Associated with Less Proteinuria and Attenuate Renal Failure Progression in Children with CKD
- (2015) R. Shroff et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
- (2015) S. Pelletier et al. OSTEOPOROSIS INTERNATIONAL
- Sclerostin, Osteocytes, and Chronic Kidney Disease - Mineral Bone Disorder
- (2015) Rosa M. A. Moysés et al. SEMINARS IN DIALYSIS
- Markers of Bone Metabolism Are Affected by Renal Function and Growth Hormone Therapy in Children with Chronic Kidney Disease
- (2015) Anke Doyon et al. PLoS One
- Altered Osteocyte-Specific Protein Expression in Bone after Childhood Solid Organ Transplantation
- (2015) Renata C. Pereira et al. PLoS One
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Effect of supplemental vitamin D and calcium on serum sclerostin levels
- (2014) Bess Dawson-Hughes et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Soluble α-Klotho and Its Relation to Kidney Function and Fibroblast Growth Factor-23
- (2014) Alexandra Scholze et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Sclerostin and Adverse Outcomes in Nondialyzed Chronic Kidney Disease Patients
- (2014) Mehmet Kanbay et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
- (2014) M. C. Hu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Circulating α-Klotho Levels in CKD and Relationship to Progression
- (2013) Hyoung Rae Kim et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Disordered FGF23 and Mineral Metabolism in Children with CKD
- (2013) A. A. Portale et al. Clinical Journal of the American Society of Nephrology
- Renal Elimination of Sclerostin Increases With Declining Kidney Function
- (2013) Daniel Cejka et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Early chronic kidney disease–mineral bone disorder stimulates vascular calcification
- (2013) Yifu Fang et al. KIDNEY INTERNATIONAL
- Influence of Cholecalciferol Supplementation in Hemodialysis Patients on Monocyte Subsets: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2013) Eric Seibert et al. NEPHRON CLINICAL PRACTICE
- Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4–5
- (2013) Eva Gravesen et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial
- (2012) Jessica A Alvarez et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Ergocalciferol Supplementation in Children with CKD Delays the Onset of Secondary Hyperparathyroidism: A Randomized Trial
- (2012) R. Shroff et al. Clinical Journal of the American Society of Nephrology
- Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy
- (2012) Yves Sabbagh et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Change in Plasma 25-Hydroxyvitamin D Did Not Differ between Breast-Fed Infants That Received a Daily Supplement of Ergocalciferol or Cholecalciferol for 3 Months
- (2012) Sina Gallo et al. JOURNAL OF NUTRITION
- Calcium Deficiency Reduces Circulating Levels of FGF23
- (2012) M. E. Rodriguez-Ortiz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet
- (2012) Wei Ling Lau et al. KIDNEY INTERNATIONAL
- Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D
- (2012) P. Marckmann et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease
- (2012) Mandy Wan et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase
- (2012) D.-C. Fischer et al. ANNALS OF CLINICAL BIOCHEMISTRY
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) Study: Objectives, Design, and Methodology
- (2010) U. Querfeld et al. Clinical Journal of the American Society of Nephrology
- Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
- (2010) Matthew T. Drake et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
- (2010) Mahmut I. Yilmaz et al. KIDNEY INTERNATIONAL
- KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 Update
- (2009) National Kidney Foundation AMERICAN JOURNAL OF KIDNEY DISEASES
- New Equations to Estimate GFR in Children with CKD
- (2009) G. J. Schwartz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis
- (2008) Katherine Wesseling-Perry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Evidence for Persistent Vitamin D 1-Alpha-Hydroxylation in Hemodialysis Patients: Evolution of Serum 1,25-Dihydroxycholecalciferol after 6 Months of 25-Hydroxycholecalciferol Treatment
- (2008) G. Jean et al. NEPHRON CLINICAL PRACTICE
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started